64Cu-SARTATE Shows Strong Tumor Detection in NET Patients
June 5, 2025
Topline data from Clarity’s diagnostic Phase II trial, DISCO, confirms that 64Cu-SARTATE is safe and highly effective compared to standard-of-care (SOC) imaging at detecting lesions in patients